246 related articles for article (PubMed ID: 35753156)
1. Association between obstructive sleep apnea and Alzheimer's disease-related blood and cerebrospinal fluid biomarkers: A meta-analysis.
Kang J; Tian Z; Wei J; Mu Z; Liang J; Li M
J Clin Neurosci; 2022 Aug; 102():87-94. PubMed ID: 35753156
[TBL] [Abstract][Full Text] [Related]
2. Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk?
Liguori C; Mercuri NB; Nuccetelli M; Izzi F; Cordella A; Bernardini S; Placidi F
Sleep Med; 2019 Apr; 56():171-176. PubMed ID: 30799255
[TBL] [Abstract][Full Text] [Related]
3. Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer's Disease Biomarkers Changes.
Liguori C; Mercuri NB; Izzi F; Romigi A; Cordella A; Sancesario G; Placidi F
Sleep; 2017 May; 40(5):. PubMed ID: 28329084
[TBL] [Abstract][Full Text] [Related]
4. A systematic review with meta-analysis to assess Alzheimer's disease biomarkers in adults with or without obstructive sleep apnoea.
Mohammadi I; Adibparsa M; Najafi A; Sehat MS; Sadeghi M
Int Orthod; 2023 Dec; 21(4):100814. PubMed ID: 37776696
[TBL] [Abstract][Full Text] [Related]
5. The association of obstructive sleep apnea with blood and cerebrospinal fluid biomarkers of Alzheimer's dementia - A systematic review and meta-analysis.
Yeo BSY; Koh JH; Ng ACW; Loh S; See A; Seow DCC; Toh ST
Sleep Med Rev; 2023 Aug; 70():101790. PubMed ID: 37245474
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Alzheimer's disease-related biomarkers in patients with obstructive sleep apnea: A systematic review and meta-analysis.
Cui W; Duan Z; Li Z; Feng J
Front Aging Neurosci; 2022; 14():902408. PubMed ID: 36313031
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment.
Díaz-Román M; Pulopulos MM; Baquero M; Salvador A; Cuevas A; Ferrer I; Ciopat O; Gómez E
Sleep; 2021 Jan; 44(1):. PubMed ID: 32728730
[TBL] [Abstract][Full Text] [Related]
10. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
[TBL] [Abstract][Full Text] [Related]
11. Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes.
Bubu OM; Pirraglia E; Andrade AG; Sharma RA; Gimenez-Badia S; Umasabor-Bubu OQ; Hogan MM; Shim AM; Mukhtar F; Sharma N; Mbah AK; Seixas AA; Kam K; Zizi F; Borenstein AR; Mortimer JA; Kip KE; Morgan D; Rosenzweig I; Ayappa I; Rapoport DM; Jean-Louis G; Varga AW; Osorio RS;
Sleep; 2019 Jun; 42(6):. PubMed ID: 30794315
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.
Almeida RP; Schultz SA; Austin BP; Boots EA; Dowling NM; Gleason CE; Bendlin BB; Sager MA; Hermann BP; Zetterberg H; Carlsson CM; Johnson SC; Asthana S; Okonkwo OC
JAMA Neurol; 2015 Jun; 72(6):699-706. PubMed ID: 25893879
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
14.
Fernandes M; Mari L; Chiaravalloti A; Paoli B; Nuccetelli M; Izzi F; Giambrone MP; Camedda R; Bernardini S; Schillaci O; Mercuri NB; Placidi F; Liguori C
J Neurol; 2022 Oct; 269(10):5356-5367. PubMed ID: 35608659
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
[TBL] [Abstract][Full Text] [Related]
17. Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort.
Law LL; Sprecher KE; Dougherty RJ; Edwards DF; Koscik RL; Gallagher CL; Carlsson CM; Zetterberg H; Blennow K; Asthana S; Sager MA; Hermann BP; Johnson SC; Cook DB; Bendlin BB; Okonkwo OC
J Alzheimers Dis; 2019; 69(1):111-121. PubMed ID: 30958346
[TBL] [Abstract][Full Text] [Related]
18. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature.
Diniz BS; Pinto Júnior JA; Forlenza OV
World J Biol Psychiatry; 2008; 9(3):172-82. PubMed ID: 17886169
[TBL] [Abstract][Full Text] [Related]
19. Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer's disease.
Cheng Y; Ren JR; Jian JM; He CY; Xu MY; Zeng GH; Tan CR; Shen YY; Jin WS; Chen DW; Li HY; Yi X; Zhang Y; Bu XL; Wang YJ
Transl Psychiatry; 2022 May; 12(1):194. PubMed ID: 35538065
[TBL] [Abstract][Full Text] [Related]
20. Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment.
He B; Wang L; Xu B; Zhang Y;
Neurosci Lett; 2021 May; 754():135765. PubMed ID: 33667602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
